Volume 14, supplement issue 1, August 2013

Chronic natriuretic peptide protein therapeutics

Authors

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O1

Increased nitrosative/oxidative stress lowers myocardial protein kinase G activity in heart failure with preserved ejection fraction

Authors (first, second and last of 13)

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O2

Abstract not submitted for publication

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O3

Lessons from tissue-specific KO of CNP/GC-B system - everlasting challenge to clinical application

Authors (first, second and last of 7)

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O4

What have genome-wide association studies taught us about cGMP and blood pressure regulation?

Authors

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O5

Genetic variants in guanylyl cyclase and phoshodiesterase affecting coronary disease risk

Authors

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O6

Genetic variants of ANP and cardiometabolic protection: from populations to novel therapeutics

Authors (first, second and last of 13)

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O7

Genetic modifiers of hypertension in sGC-deficient mice

Authors

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O8

Pulmonary vascular adaptation to high-altitude living

Authors

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O9

MicroRNA miR-425 is a negative regulator of atrial natriuretic peptide

Authors (first, second and last of 13)

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O10

cGMP kinase: past, presence and future

Authors (first, second and last of 5)

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O11

Conformational changes involved in sGC activation

Authors (first, second and last of 5)

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O12

A twenty year journey to understand how ATP activates guanylyl cyclase A and B

Authors

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O13

Soluble guanylate cyclase crystal clear: 1^stcrystal structure of the wild-type human heterodimeric sGC catalytic domains and implications for activity

Authors

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O14

Crystal structures of human soluble guanylate cyclase catalytic domains: promiscuity of the dimer interface and a potential allosteric site

Authors

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O15

Structures of human PKG reveal cGMP-selectived activation mechanisms

Authors (first, second and last of 15)

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O16

Targeting native and apo-sGC

Authors (first, second and last of 6)

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O17

Mechanisms driving heme insertion into apo-sGC during its maturation in cells

Authors (first, second and last of 4)

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O18

Redox signalling by protein kinase G Iα in cardiovascular physiology and pathology

Authors

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O19

New mechanisms of normoxic and hypoxic cGMP signalling mediated by the nitrite anion

Authors

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O20

Thiol-redox proteins interact with soluble guanylyl cyclase and modulate its activity

Authors (first, second and last of 6)

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O21

Chronic beta-adrenergic blockade prevents volume overload-induced re-localization and oxidation of soluble guanylyl cyclase

Authors (first, second and last of 4)

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O22

Elementary Ca²⁺signals through endothelial TRPV4 channels regulate vascular function

Authors (first, second and last of 7)

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O23

Natriuretic peptides and fat metabolism

Authors

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O24

Role of cGMP in fat and metabolism

Authors

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O25

Non-genomic thyroid hormone signaling through NO/cGMP/PKGII

Authors (first, second and last of 8)

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O26

cGMP-Prkg1 signaling PDE5 inhibition shelter cochlear hair cells and hearing function

Authors (first, second and last of 8)

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O27

GUCY2C at the intersection of obesity and colorectal cancer

Authors (first, second and last of 8)

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O28

Cell type-specific knock out models to unravel NO/cGMP signaling in smooth muscle

Authors (first, second and last of 5)

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O29

Interstitial cells of Cajal link excitatory and nitrergic inhibitory neurotransmission with slow-wave activity in the intestine

Authors (first, second and last of 15)

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O30

cGMP-dependent kinase 2, Na⁺/H⁺ regulatory factor 2, and Na⁺/H⁺ exchanger isoform 3 assemble within lipid rafts in murine small intestinal brush border membrane

Authors (first, second and last of 16)

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O31

NO-H₂S interactions involve cGMP

Authors

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O32

67-kDa laminin receptor and cGMP induced cancer-selective apoptosis

Authors

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O33

A novel physiological significance of natriuretic peptides in cancer metastasis

Authors (first, second and last of 5)

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O34

Dual actions of ANP on endothelial permeability

Authors (first, second and last of 14)

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O35

Pseudomonas aeruginosaExoY, a cyclic GMP- and cyclic UMP-generating nucleotidyl cyclase

Authors (first, second and last of 13)

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O36

Nitric oxide regulated cyclic di-GMP signaling

Authors (first, second and last of 6)

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O37

Differential effects of PDE5 inhibitors on cardiac dysfunction in the MDX ouse model of Duchenne muscular dystrophy

Authors (first, second and last of 11)

• Content type: Oral presentation
• Open Access
• Published: 29 August 2013
• Article: O38

Neutral endopeptidase inhibitors SOL-1 and candoxatril counteract kidney fibrosis by reducing myofibroblast formation in mouse UUO model

Authors (first, second and last of 9)

• Content type: Poster presentation
• Open Access
• Published: 29 August 2013
• Article: P1

Hydroxyurea reduces leukocyte interactions with the vessel wall in a haemolytic mouse model via a possible NO/cGMP-mediated effect

Authors (first, second and last of 6)

• Content type: Poster presentation
• Open Access
• Published: 29 August 2013
• Article: P2

Effect of nitrite treatment on endothelial nitric oxide synthase in human left ventricle biopsy

Authors (first, second and last of 6)

• Content type: Poster presentation
• Open Access
• Published: 29 August 2013
• Article: P3

A possible crosstalk between cGMP pathway and Activin receptor-like kinase 7 (Alk7) in adipocytes

Authors (first, second and last of 4)

• Content type: Poster presentation
• Open Access
• Published: 29 August 2013
• Article: P4

Pharmacokinetic interaction of ketoconazole, clarithromycin, and midazolam with riociguat

Authors (first, second and last of 9)

• Content type: Poster presentation
• Open Access
• Published: 29 August 2013
• Article: P5

Effects of omeprazole and AlOH/MgOH on riociguat absorption

Authors (first, second and last of 6)

• Content type: Poster presentation
• Open Access
• Published: 29 August 2013
• Article: P6

Absorption behavior of riociguat: bioavailability, food effects, and dose-proportionality

Authors (first, second and last of 6)

• Content type: Poster presentation
• Open Access
• Published: 29 August 2013
• Article: P7

Role of NO-sensitive guanylyl cyclase in angiogenesis and arteriogenesis

Authors

• Content type: Poster presentation
• Open Access
• Published: 29 August 2013
• Article: P8

NO-cGMP signalling and cancer therapy

Authors (first, second and last of 7)

• Content type: Poster presentation
• Open Access
• Published: 29 August 2013
• Article: P9

Identification of protein kinase G I alpha interacting proteins as potential targets to prevent cardiac remodeling

Authors (first, second and last of 9)

• Content type: Poster presentation
• Open Access
• Published: 29 August 2013
• Article: P10

G-protein signaling modulator 1 is a modifier of sGC-dependent vascular response

Authors

• Content type: Poster presentation
• Open Access
• Published: 29 August 2013
• Article: P11

Identification and quantitation of 2´,3´-cGMP in murine tissues

Authors (first, second and last of 4)

• Content type: Poster presentation
• Open Access
• Published: 29 August 2013
• Article: P12